Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA.

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

AltiBio is a biopharmaceutical company that involves in developing and commercializing orphan therapeutics.

KIM Co., Ltd., part of Tan Entertainment, is a South Korean company located in Changwon. The firm manufactures precision gears and driving devices.

Manufactures pharmaceuticals

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

Provides digital urine meters which measures biofilm build-up

Part of Rinnai Corp., Rinnai Korea Corp. is a South Korean company located in Inchon. The firm manufactures and wholesales gas ranges and boilers and kitchen appliances. It was founded in 1974.

TOTO Ltd. engages in the manufacture and sale of restroom, bath & kitchen equipment, ceramics, and eco-friendly materials. It operates through the following segments: Global Housing Equipment Business, New Business Domains, and Others. The Global Housing Equipment Business segment handles the sale of housing equipment which includes sanitary ware, faucets, and systems kitchen. The New Business Domains segment covers environmental and ceramic products. The Others segment includes the real estate leasing business. It is also divided into three regions namely Japan, China and Asia, and Americas and Europe. The company was founded by Kazuchika Okura on May 15, 1917 and is headquartered in Kitakyushu, Japan.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Aofei (Taizhou) Photoelectric Sensing Technology Co., Ltd., established on 2018-06-04, Business scope includes photoelectric sensor technology,Internet of things technology research and development,Research and Development of Optical Measuring Instruments,Sales and technical consulting services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Haosi Biotechnology Co., Ltd., established on 2016-03-18, The business scope includes the sale of Class III medical devices;biotechnology development,consult,to promote,Serve;Import and export;Technology Import and Export;sell medical devicesI,IIkind,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Equipment;Machinery and Equipment Leasing(Car rental not included);Chemical Reagent and Auxiliary Manufacturing(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Wuhan Kangfude Biotechnology Co. Ltd. engages in the development of non-invasive prevention and treatment of kidney stones. It offers oxalate degrading enzyme, vitro diagnostic kit for urine oxalic acid, and low oxalate instant tea. The company offer the health products according to test result. It also provide regular urine testing, health tracking and other health related services. Wuhan Kangfude Biotechnology was founded on August 24, 2010 and is headquartered in Wuhan, China.

Beijing Jitai Keshi Instrument Technology Co., Ltd., established on 2011-11-01, Business scope includes technology development;technology transfer;technical consulting;Technical Services;Instrumentation,Research and development of electronic products(Including prototype manufacturing,detection);Computer System Services;Engineering and Technology Research and Experimental Development;translation service;Sales of machinery and equipment,electronic product,Computer software and auxiliary equipment,communication equipment;Construction Project Management;Construction General Contracting;Professional contractors;Engineering survey and design.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Engineering Investigation,engineering design,Construction General Contracting,Professional contracting and projects subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jiangsu Haosimoco Biotechnology Co., Ltd., established on 2019-07-23, Business scope includes biological,Technology development in the field of medical technology,technical consulting,Technical Services,Technology Promotion and Technology Transfer;Production and sales of medical devices(Operate according to the approved scope of medical devices);Chemical Products(Free of hazardous chemicals and precursor chemicals)promotion of;Production, sales and leasing of machinery and equipment;Import and export business of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.